Jared Watkin - 28 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Jared Watkin by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
28 Feb 2022
Net transactions value
-$949,958
Form type
4
Filing time
02 Mar 2022, 19:02:59 UTC
Previous filing
23 Feb 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability $827,369 -6,759 -9.1% $122.41 67,583 28 Feb 2022 Direct
transaction ABT Common shares without par value Sale $122,589 -1,038 -1.5% $118.10 66,545 01 Mar 2022 Direct
holding ABT Common shares without par value 622 28 Feb 2022 Profit Sharing Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2022.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).